Resources
Highlights from London Calling
Discover how researchers are using Oxford Nanopore sequencing to generate new insights across diverse applications.
:quality(80))
Discover nanopore sequencing
- What it can do
- How it’s being used
- How to get started
Latest protocols
:quality(80))
Pharmacogenomic (PGx) sequencing workflow with adaptive sampling (blood, cells, saliva)
Long read de novo sequencing from blood and cells using SQK-ULK114 – resolve method
Long read de novo sequencing from blood using SQK-LSK114 – scale method
Rapid sequencing DNA V14 - barcoding (SQK-RBK114.24 or SQK-RBK114.96)
Rapid Sequencing Kit V14 - gDNA (SQK-RAD114)
Microbial amplicon barcoding for 16S and ITS – automated ElysION MinION (SQK-MAB114.24)
Webinars and events
:quality(80))
Unlocking high-resolution, strain-resolved microbiome analyses | ASM Microbe 26
During this video we learn how full length Oxford Nanopore sequencing is unlocking high-resolution microbiome analyses
:quality(80))
Oxford Nanopore at AMP 2026
Oxford Nanopore Technologies are exhibiting and presenting at AMP 2026 in November.
White papers
:quality(80))
Genomics for a changing planet: sequencing the living world
Discover how a global community of researchers are harnessing Oxford Nanopore sequencing to study the far-reaching impacts of climate change, revealing deep insights across environmental research, agriculture, and pathogen surveillance.
:quality(80))
New approaches for human and clinical research
Explore the advantages of Oxford Nanopore sequencing to detect genomic and epigenomic variants in human and clinical research.
Case studies
:quality(80))
Faster analysis of cancer-associated variants using a unique targeted nanopore sequencing approach
In this case study, discover the benefits of adaptive sampling and how it has been applied to cancer research.
:quality(80))
Accurate identification of cancer-predisposing deep intronic variants in tumour-suppressor genes with Oxford Nanopore sequencing
Find out how targeted Oxford Nanopore sequencing, via adaptive sampling, can be used to systemically evaluate deep intronic variants associated with hereditary cancer risk.
Getting started guides
:quality(80))
A guide to biopharma solutions from Oxford Nanopore — from discovery to development
This guide introduces Oxford Nanopore sequencing solutions for biopharma that can be applied from biomarker discovery through to final product quality control (QC) testing.
:quality(80))
A guide to transcriptomics with Oxford Nanopore
This guide introduces cDNA and direct RNA Oxford Nanopore sequencing, for ultra-rich transcriptomic data without compromise.
Workflow overviews
:quality(80))
Real-time enrichment of a comprehensive pharmacogenomic panel with Oxford Nanopore sequencing
This end-to-end workflow introduces how to enrich a comprehensive panel of PGx targets with real-time targeted Oxford Nanopore sequencing.
:quality(80))
Comprehensive human genomic variant and methylation analysis with long Oxford Nanopore reads
This end-to-end workflow provides a scalable method to identify previously hidden and potentially pathogenic variants.
Brochures
:quality(80))
Hereditary Cancer Panel: targeted sequencing via adaptive sampling
In this flyer, discover how to utilise the Oxford Nanopore Hereditary Cancer Panel to investigate 258 key genes associated with hereditary cancer risk.
:quality(80))
Go with the gold standard in methylation sequencing
In this flyer, find out how Oxford Nanopore provides gold-standard methylation sequencing and comprehensive variant calling in a single run — without chemical conversion.
:quality(80))
Browse document repository
Quickly find the resources most relevant to your work. Filter by application, technique, product, or content type to get straight to the content that matters.
